younger patients inevitable (7). It is imperative that these younger patients are informed about the chances of revision, and on the outcome of these revisions (8-11). However, there is a lack of knowledge on the outcome of subsequent revisions in young patients. As more and more younger patients undergo operations, this could result in large numbers of patients who will have no further reconstructive options after failed hip arthroplasty in the future, which would present a large medical burden to society.
Introduction
Total hip arthroplasty (THA) is 1 of the most successful and cost-effective operations in medicine (1) . Due to its success in reducing pain and restoring mobility to near normal in older patients (2) (3) (4) (5) (6) , THA is increasingly used in younger patients who suffer from primary and secondary osteoarthritis (2, 5, 6) . Survival of a THA is often expressed as the duration to failure of 1 or both components of the total hip prosthesis for any reason, including aseptic loosening, septic loosening, trauma, recurrent dislocations, or any others. Literature shows comparable early results of THA in young patients compared to older patients, but within 10 years after surgery, a decline of the survival of the prosthesis in younger patients aged under 50 has been seen (2, 5) . This less successful survival, in combination with the fact that many young patients will outlive their primary total hip implant due to their longer life-expectancy, makes high numbers of revisions in these characteristics of the complete primary THA cohort should be included to obtain accurate information on which revision THA could be successful for an individual patient. The results of the primary hip prosthesis, the revisability of hip arthroplasties and survival of its subsequent revision should be investigated and presented together. In summary, we can state that in cases of total hip arthroplasty, any re-intervention on a hip, either to the cup or the femoral component should be considered as important, because for the patient, the overall number of re-operations and the revisability of the prosthesis are the outcome parameters that count. Therefore, survival of a prosthesis should be presented as survival of the whole construct (both acetabular-and femoral components). Furthermore, the influence of the primary construct on the revision construct should be taken into account when judging survival of total hip arthroplasty in younger patients. To the best of our knowledge, no systematic reviews are available on this topic.
We performed a systematic review of current literature regarding the available results of subsequent revision arthroplasties in cohorts of patients, who received their primary THA aged under 50 years old at the time of surgery, with a mean follow-up of 10 years after primary hip arthroplasty.
Methods
A systematic review of studies that evaluated the survival data of both primary-and revision hip arthroplasties in the same cohorts of patients who received their primary total hip implant under the age of 50 years old was performed.
The review protocol and methodology were prospectively registered in PROSPERO (registration number CRD 42016039602). The review was performed according to the PRISMA guidelines (see Supplementary material, available online at www.hip-int.com).
Eligibility criteria
To answer the research question and search for appropriate available literature that combined the results of primaryand revision total hip arthroplasties in younger patients, we used the following eligibility criteria:
(i) Studies that evaluated the survival data of both primary and revision hip arthroplasties in the same cohorts of patients who received their primary total hip implant <50 years old; (ii) with a mean follow-up of 10 years after primary THA; and (iii) that included both acetabular-and femoral components.
Review articles and case reports were excluded. Studies that presented data on hemi-arthroplasties and resurfacing arthroplasties were also excluded. Only total hip arthroplasty procedures were included.
Our primary outcome was the survival of revision arthroplasties in cohorts of patients, from whom, the survival of all primary hip arthroplasties was also described.
Survival was defined as the survival of the primary (or revision) arthroplasty, with endpoint as (re-) revision for aseptic loosening and/or any reason (including (re-)revision for aseptic loosening, septic loosening, dislocation and other causes mentioned for (re-)revision of one of the total hip components).
Only articles written in English, Dutch, German or French were considered eligible.
Search strategy
Medline (PubMed), Embase and the Cochrane Library (CENTRAL) were searched (the last search was performed April 13, 2016) for articles that reported both the survival of primary prosthesis in cohorts of patients <50 years old, as well as the survival of the subsequent revision THAs in the same cohort. Our search strategy was developed together with a medical information specialist from the Medical Library of Radboud university medical center in Nijmegen, the Netherlands. Keywords used to develop the search were 'hip prosthesis', 'revision', 'young' and 'cohort'. The detailed search strategy is provided as Supplementary material, available online at www.hip-int.com. The Cochrane Library showed evidently fewer results compared to Medline and Embase, and, therefore, we omitted the search terms related to 'cohort' and 'young' to reveal as many possible eligible articles within the Cochrane Library database.
Language limits were set to English, Dutch, German and French. The complete reference lists of the possible eligible papers were screened for potentially missed papers.
Selection of studies
After removal of duplicates, articles were screened on title and abstract by 2 independent reviewers (MS and CT). Any discrepancies were resolved by discussion.
Full text copies of eligible articles were assessed and included when they met our inclusion criteria.
Data collection process and items
Survival data of primary THA, as well as the survival of the revision THA within the same cohort, including estimated Kaplan-Meier survival or competing risk survival analysis, were extracted. In addition, the survival for aseptic loosening and/or any reason of both acetabular-and femoral components of the primary cohort were also extracted. Baseline characteristics including age, gender and body mass index (BMI) were collected, as well as fixation method (cemented, uncemented and hybrid) and indication at time of primary surgery. All of this was carried out by 2 independent reviewers (MS and CT).
Risk of bias assessment
Bias risk was assessed at study level and the quality of the included cohort studies was scored by 2 authors (CT, GH) using the Newcastle-Ottawa Scale (NOS) for assessment of the quality of non-randomised studies in meta-analysis (23) . A study could be awarded a maximum of 1 star for each of the 4 numbered items within the 'Selection' and 'Outcome' categories. A maximum of 2 stars could be given for 'Comparability'. In total, a maximum of 8 stars could be received. We used the Newcastle-Ottawa scale, as it is 1 of the 2 most useful tools of the many instruments created to assess methodological quality of non-randomised studies of interventions, and reviewed systematically by Deeks et al (24) , as described in the Cochrane Handbook for Systematic Reviews of Interventions (25) .
Subgroup analysis
If 3 or more comparable studies were available, subgroup analyses for fixation technique of the prosthesis (cemented, uncemented and hybrid) and for diagnosis at time of primary surgery were performed.
Results

Search and summary of results
Our search strategy resulted in 4,799 unique records (Fig. 1) . The subsequent selection procedure resulted in 43 potentially eligible articles, of which 1 met the inclusion criteria and could be included. This paper describes 1 of our own studies that includes patients <30 years old, and reported on 13 revisions from a primary cohort of 69 primary THAs (21) . Index surgery was performed between 1988 and 2004, and analysis was carried out in 2011. Diagnosis at time of primary surgery was described for all cases. Mean age was 25 years (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) at primary implantation. Survival of the primary prostheses with aseptic loosening as reason for revision was 90% (confidence interval [CI], 79-96) after 10 years. All primary and revision cases involved cemented implants. Mean followup of the primary cohort was 11.5 years (7-23). There were 13 revisions in this cohort. The diagnoses of these 13 hips at primary surgery were not clearly described. 3 THAs were revised for septic loosening and 10 acetabular components were revised; due to aseptic loosening, none of the stems were revised separately. Only 1 revision required a re-revision after 13 years, the reason for revision was not reported. Survival of the revision THAs was, therefore, 100% after 10 years.
Quality assessment
According to the Newcastle-Ottawa Scale (NOS), 3 out of 4 stars were awarded for 'selection'. 'Comparability' was not applicable, as no comparison of cohorts was performed. Regarding 'outcome', 3 out of 3 stars were awarded.
Subgroup analysis
Subgroup analysis was not performed, as only one study could be included.
Discussion
Comparison to literature
We identified only 1 study reporting on revisions, whilst reporting on the survival of the primary THA cohort in patients <50 years old. This is a striking result, as we know from studies including patients of all ages that it is important to be familiar with the effect of the primary implant and the fixation technique used on the results of revision. For example, Lie et al (26) reported on 78,534 primary operations that included people of all ages with a median follow-up of 5.6 years, and found the probability of requiring revision surgery within 10 years for all primary operations to be 11.4% (95% CI, 11.3 to 11.4). Whereas for the subsequent revisions, with no infection, the 10-year risk of failure was 25.6% (95% CI, 24.8 to 26.4), which emphasises the higher failure risk of revisions compared to primary prosthesis. Both acetabular and femoral components showed different survival rates per revision technique, which stresses the importance of obtaining more knowledge on the influence of the primary implant and its fixation technique in success of the final revision. Although total hip arthroplasty for younger patients has been acclaimed as a reliable solution, one might say that this is still based on incomplete data that lacks subsequent revision outcomes.
Remarkably, there is a growing body of literature that has reported on cohorts of THA in younger patients with primary outcomes (2, 12, 14, 15, 17, (27) (28) (29) (30) (31) , even including follow-up of >25 years (16, 18, 19) . Overall, there are also a few studies that report on revision THA in younger patients. Such studies are of clinical importance and do meet some of our inclusion criteria, however, none report data on revision arthroplasty in combination with results of the primary THA cohort (8, 9, 11, (32) (33) (34) (35) (36) . Often, the authors solely present a subgroup of their cohort and the primary survival data are omitted. The characteristics of the original primary THA, including the type of component, fixation technique and baseline characteristics of patients are omitted. Furthermore, information on the survival of the primary component that was revised is not complete. For example, it is important to know if the primary component already failed before it even reached a follow-up of 10 years, or, in cases of an acetabular component revision, it is useful to know if the femoral component was also exchanged in the meantime.
So, the literature on revisions in younger patients appears to be selectively reported. This selective reporting of revision THA outcome is alarming, as we cannot determine which of the revised patients had a durable primary implant and what patient characteristics and fixation techniques might have contributed to the reported survival results. Survival data of THA in younger patients have also been published in National Joint Registries (2, 5, 37) , and can be helpful to indicate trends or record differences in outcomes with otherwise extremely low incidence (37) (38) (39) (40) . Although these registers currently do not always reveal complete information about the initial diagnosis, survival of the primary implant or the radiographical images at time of revision (41), they do have the potential to fulfill these needs in the future. Furthermore, a great advantage of a national registry is that it will not miss any revision for any cause and is able to compare outcomes following different methods of revision performed in different centres. The lack of evidence regarding the combined primary and revision results up to today illustrates that registries should continue to closely monitor all patients in order to gain more knowledge on this and improve care for this specific group of patients.
Possible explanations
A possible explanation of the lack of information available could be the use of the resurfacing prosthesis. After its re-introduction in the 1990s, the resurfacing prosthesis became quite popular, especially for use in the younger patient, and this could have impacted the number of cohorts of younger patients receiving THA. An additional explanation for our findings could be that collecting data such as primary-and subsequent revision arthroplasty outcomes requires strict and intensive follow-up of young patients, as also suggested by others (8) (9) (10) (11) . As revisions are often performed in specialised referral centres, practice can lead to mixed cohorts, or a number of patients lost to follow-up. On the other hand, primary cohorts of patients that have been described already years ago in literature should be described again somewhere in time to present their revision outcome as well. Even though these results might show varying success rates or include old techniques, the information can help in defining the best treatment options for younger patients suffering from osteoarthritis, espec ially when radiographic follow-up is complete. It should be emphasised that THA in young patients is often a continuous process of multiple surgeries, and that we currently miss essential 'pieces of the puzzle' in the literature.
Limitations
There are some limitations to our study that should be discussed. Firstly, as we included studies that reported on patients of 50 years old and younger at the time of primary surgery, we might have excluded studies that have reported on patients aged <65 years or older and might include subgroups of younger age. Secondly, by including only cohorts that present at least a mean follow-up of 10 years of their primary prosthesis, we might have excluded some useful articles that presented revision data. Furthermore, it must be realised that revision rates capture not all the implants that clinically fail but have not been treated surgically. We consider that with the currently available results of hip arthroplasty, presenting results at shorter follow-up would not yield any representative and useful results for clinical practice. Thirdly, by including articles reporting on both components, we might have excluded those reporting on only acetabular -or femoral components. The reason for this is that the results of only 1 component are of lower clinical relevance to patients in discussing survival. Lastly, we have appraised the quality of our own study. We have performed this as accurately and completely as possible.
Conclusion
There is this little information available on the revisability of hip prosthesis in young patients.
We should be aware of selective outcome reporting in younger patients in treating those patients with end-stage osteoarthritis, as we cannot currently adequately inform younger patients on their future survival expectations regarding different THA techniques. This could potentially lead to large numbers of patients with hips that cannot be reconstructed and can generate high medical costs for societies.
